Angiotensin II and nitric oxide interaction

被引：7

作者：

De Gasparo M. ^{[1
]}

机构：

[1] MG Consulting Co., 2842 Rossemaison

来源：

Heart Failure Reviews | 2002年 / 7卷 / 4期

关键词：

Angiotensin receptor antagonist; Endothelial dysfunction; NADPH oxidase; NOS; Oxidative stress; Superoxide;

D O I：

10.1023/A:1020714518246

中图分类号：

学科分类号：

摘要：

Nitric oxide degradation linked to endothelial dysfunction plays a central role in cardiovascular diseases. Superoxide producing enzymes such as NADPH oxidase and xanthine oxidase are responsible for NO degradation as they generate a variety of reactive oxygen species (ROS). Moreover, superoxide is rapidly degraded by superoxide dismutase to produce hydrogen peroxide leading to the uncoupling of NO synthase and production of increased amount of superoxide. Angiotensin II is an important stimulus of NADPH oxidase. Through its AT1 receptor, Ang II stimulates the long-term increase of several membrane component of NADPH oxidase such as P22 phox or nox-1 and causes an increased activity of NADPH oxidase with inactivation of NO leading to impaired endothelium-dependent vasorelaxation, vascular smooth muscle cell hypertrophy, proliferation and migration, extracellular matrix formation, thrombosis, cellular infiltration and inflammatory reaction. Several preclinical and clinical studies have now confirmed the involvement of the AT1 receptor in endothelial dysfunction. It is proposed that the AT2 receptor counterbalances the deleterious effect of the Ang II-induced AT1 receptor stimulation through bradykinin and NOS stimulation. This mechanism could be especially relevant in pathological cases when the NADPH oxidase activity is blocked with an AT1 receptor antagonist.

引用

页码：347 / 358

页数：11

共 128 条

[1]

Hilgers K.F., Veelken R., Muller D.N., Kohler H., Hartner A., Botkin S.R., Stumpf C., Schmieder R.E., Gomez R.A., Renin uptake by the endothelium mediates vascular angiotensin formation, Hypertension, 38, pp. 243-248, (2001)

[2]

Rubanyi G.M., Vanhoutte P.M., Superoxide anions and hyperoxia inactive endothelium-derived relaxing factor, Am J Physiol, 250, (1986)

[3]

Taddei S., Virdis A., Mattei P., Arzilli F., Salvetti A., Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension, J Card Vasc Pharmacol, 20, SUPPL. 12, (1999)

[4]

Gaeta G., De Michele M., Cuomo S., Guarini P., Foglia M.C., Bond M.G., Trevisan M., Arterial abnormalities in the offspring of patients with premature myocardial infarction, N Engl J Med, 343, pp. 840-846, (2000)

[5]

McIntyre M., Bohr D.F., Dominiczak A.F., Endothelial function in hypertension: The role of superoxide anion, Hypertension, 34, pp. 539-545, (1999)

[6]

Griendling K.K., Sorescu D., Ushio-Fukai M., NAD(P)H oxidase: Role in cardiovascular biology and disease, Circ Res, 86, pp. 494-501, (2000)

[7]

Cai H., Harrison D.G., Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress, Circ Res, 87, pp. 840-844, (2000)

[8]

Ruiz-Ortega M., Lorenzo O., Ruperez M., Esteban V., Suzuki Y., Mazzano S., Plaza J.J., Egido J., Role of the renin-angiotensin system in vascular diseases. Expanding the field, Hypertension, 38, pp. 1382-1387, (2001)

[9]

Griendling K.K., Ushio-Fukai M., Reactive oxygen species as mediators of angiotensin II signaling, Regul Pept, 91, pp. 21-27, (2000)

[10]

Dzau V.J., Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis, Hypertension, 37, pp. 1047-1052, (2001)

← 1 2 3 4 5 6 7 8 9 10 →